<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We previously reported a strong IL4I1 gene expression in primary mediastinal B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (PMBL) and recently identified the protein as a secreted <z:chebi fb="0" ids="17295,29997">L-phenylalanine</z:chebi> oxidase, physiologically expressed by myeloid cells, which inhibits T-cell proliferation in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we analyzed the pattern of IL4I1 protein expression in 315 human lymphoid and non-lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Besides PMBL, IL4I1 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> was very frequent </plain></SENT>
<SENT sid="3" pm="."><plain>IL4I1 was detected in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated macrophages from most of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and in neoplastic cells from follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, classic and nodular lymphocyte predominant Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, three of which are germinal center derived </plain></SENT>
<SENT sid="4" pm="."><plain>IL4I1-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells were also detected in rare cases of solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, mainly <z:mpath ids='MPATH_365'>mesothelioma</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>The enzymatic activity paralleled protein expression, suggesting that IL4I1 is functional in vivo </plain></SENT>
<SENT sid="6" pm="."><plain>Depending on the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type, IL4I1 may impact on different infiltrating lymphocyte populations with consequences on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> evolution </plain></SENT>
<SENT sid="7" pm="."><plain>In the particular case of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, which are susceptible to antitumor cytotoxic T cells killing but depend on interactions with local T helper cells for survival, a high level of IL4I1 expression seems associated with the absence of bone marrow involvement and a better outcome </plain></SENT>
<SENT sid="8" pm="."><plain>These findings plead for an evaluation of IL4I1 as a prognosis factor </plain></SENT>
</text></document>